Literature DB >> 11825832

Validation of the pulmonary score: an asthma severity score for children.

Sharon R Smith1, Jack D Baty, Dee Hodge.   

Abstract

OBJECTIVES: In the absence of a validated "user-friendly" method of scoring asthma severity, the authors derived the pulmonary score (PS). The purpose of this study was to begin validation trials of the PS by comparing it with the peak expiratory flow rate (PEFR).
METHODS: The study enrolled a convenience sample of children, aged 5-17 years, who came to the emergency department (ED) for treatment of an acute asthma exacerbation. The PEFR (best of three attempts) and the PS were measured before and after the first albuterol treatment by a physician and a nurse from a pool of 45 trained observers. The PS includes respiratory rate, wheezing, and retractions, each rated on a 0-3 scale. Decreasing PS and increasing PEFR indicate clinical improvement. Pre- and post-treatment PEFRs and PSs were compared using paired t-tests to establish construct validity. Correlation of pre- and post-treatment PSs with PEFRs was measured to establish criterion validity.
RESULTS: Forty-six subjects completed the study. Mean percent predicted PEFR improved after treatment by 20.7% (p = 0.0001), and mean PS by 1.5 for nursing-obtained scores (p < 0.0001) and 1.9 for physician-obtained scores (p < 0.0001). Pre- and post-treatment PSs were significantly correlated with PEFRs. Correlations for the nursing-obtained scores were pre-treatment r = -0.57 (p = 0.0003) and post-treatment r = -0.67 (p = 0.0001), and for the physician-obtained scores were pre-treatment r = -0.44 (p = 0.003) and post-treatment r = -0.56 (p = 0.0001). The pre-treatment interrater reliability was 0.62 and the post-treatment was 0.53.
CONCLUSIONS: These data support the construct and criterion validities of the PS as a measure of asthma severity among children in the ED. The PS is a practical substitute to estimate airway obstruction in children who are too young or too sick to obtain PEFRs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825832     DOI: 10.1111/j.1553-2712.2002.tb00223.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  16 in total

1.  Exhaled nitric oxide levels during treatment of pediatric acute asthma exacerbations and association with the need for hospitalization.

Authors:  Kyle A Nelson; Pearlene Lee; Kathryn Trinkaus; Robert C Strunk
Journal:  Pediatr Emerg Care       Date:  2011-04       Impact factor: 1.454

2.  Feasibility of short-term infusion of magnesium sulfate in pediatric patients with status asthmaticus.

Authors:  Jose Irazuzta; Tosha Egelund; Sarah K Wassil; Christian Hampp
Journal:  J Pediatr Pharmacol Ther       Date:  2012-04

Review 3.  Asthma outcomes: exacerbations.

Authors:  Anne Fuhlbrigge; David Peden; Andrea J Apter; Homer A Boushey; Carlos A Camargo; James Gern; Peter W Heymann; Fernando D Martinez; David Mauger; William G Teague; Carol Blaisdell
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

4.  A tree-based decision model to support prediction of the severity of asthma exacerbations in children.

Authors:  Ken Farion; Wojtek Michalowski; Szymon Wilk; Dympna O'Sullivan; Stan Matwin
Journal:  J Med Syst       Date:  2009-03-11       Impact factor: 4.460

5.  Effect of a clinical pathway on the hospitalisation rates of children with asthma: a prospective study.

Authors:  S P Norton; M V Pusic; F Taha; S Heathcote; B C Carleton
Journal:  Arch Dis Child       Date:  2006-08-11       Impact factor: 3.791

6.  Serum total and free carnitine levels in children with asthma.

Authors:  Suna Asilsoy; Ozlem Bekem; Ozkan Karaman; Nevin Uzuner; Salih Kavukçu
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

7.  Comparison of Two High-Dose Magnesium Infusion Regimens in the Treatment of Status Asthmaticus.

Authors:  Danish Vaiyani; Jose E Irazuzta
Journal:  J Pediatr Pharmacol Ther       Date:  2016 May-Jun

8.  Ohio Pediatric Asthma Repository: Opportunities to Revise Care Practices to Decrease Time to Physiologic Readiness for Discharge.

Authors:  Jeffrey M Simmons; Jocelyn M Biagini Myers; Lisa J Martin; Carolyn M Kercsmar; Christine L Schuler; Valentina V Pilipenko; John W Kroner; Hua He; Stephen R Austin; Huyen-Tran Nguyen; Kristie R Ross; Karen S McCoy; Sherman J Alter; Samantha M Gunkelman; Pierre A Vauthy; Gurjit K Khurana Hershey
Journal:  Hosp Pediatr       Date:  2018-05-15

9.  Development and Validation of a New Clinical Scale for Infants with Acute Respiratory Infection: The ReSVinet Scale.

Authors:  Antonio José Justicia-Grande; Jacobo Pardo-Seco; Miriam Cebey-López; Lucía Vilanova-Trillo; Alberto Gómez-Carballa; Irene Rivero-Calle; María Puente-Puig; Carmen Curros-Novo; José Gómez-Rial; Antonio Salas; José María Martinón-Sánchez; Lorenzo Redondo-Collazo; Carmen Rodríguez-Tenreiro; Federico Martinón-Torres
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

10.  The profile of leucocytes, CD3+, CD4+, and CD8+ T cells, and cytokine concentrations in peripheral blood of children with acute asthma exacerbation.

Authors:  Thuy Nguyen-Thi-Dieu; Huong Le-Thi-Thu; Sy Duong-Quy
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.